Forward Management, LLC Catalent, Inc. Transaction History

Forward Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 01, 2019	SELL	$29.95 - $46.34 $170,355 - $263,581	-5,688 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$40.12 - $45.55 $46,138 - $52,382	-1,150 Reduced 16.82%	5,688 $259,000
Q2 2018 Aug 01, 2018	BUY	$38.72 - $42.52 $7,744 - $8,504	200 Added 3.01%	6,838 $287,000
Q1 2018 Apr 30, 2018	BUY	$39.4 - $47.39 $4,137 - $4,975	105 Added 1.61%	6,638 $272,000
Q4 2017 Feb 02, 2018	SELL	$37.27 - $43.02 $7,826 - $9,034	-210 Reduced 3.11%	6,533 $269,000
Q3 2017 Nov 02, 2017	BUY	$33.75 - $41.67 $227,576 - $280,980	6,743	6,743 $269,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Forward Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Forward Management, LLC with notifications on news.